1. Home
  2. TRVI vs KSS Comparison

TRVI vs KSS Comparison

Compare TRVI & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$13.84

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Kohl's Corporation

KSS

Kohl's Corporation

HOLD

Current Price

$14.85

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVI
KSS
Founded
2011
1962
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
TRVI
KSS
Price
$13.84
$14.85
Analyst Decision
Strong Buy
Sell
Analyst Count
11
15
Target Price
$21.55
$15.31
AVG Volume (30 Days)
1.6M
3.6M
Earning Date
05-08-2026
05-28-2026
Dividend Yield
N/A
3.28%
EPS Growth
31.91
142.86
EPS
N/A
2.38
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.21
P/E Ratio
N/A
$6.39
Revenue Growth
N/A
N/A
52 Week Low
$5.38
$6.47
52 Week High
$16.12
$25.22

Technical Indicators

Market Signals
Indicator
TRVI
KSS
Relative Strength Index (RSI) 54.32 53.54
Support Level $10.07 $13.98
Resistance Level $13.97 $16.95
Average True Range (ATR) 0.86 0.78
MACD -0.07 0.20
Stochastic Oscillator 30.40 54.06

Price Performance

Historical Comparison
TRVI
KSS

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

About KSS Kohl's Corporation

Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.

Share on Social Networks: